Repurposing a cholesterol drug candidate for cholestatic liver disease

News | 06. 19. 2013

Lumena Pharmaceuticals

June 19, 2013

Lumena Pharmaceuticals Inc. is converting a compound previously tested as a cholesterol-lowering agent into an experimental treatment for cholestatic liver diseases. The molecule inhibits a so-called transporter that normally helps the body recycle bile acid.